These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19162790)

  • 1. Assessment of vessel size by MRI in an orthotopic model of human pancreatic cancer.
    Flexman JA; Yung A; Yapp DT; Ng SS; Kozlowski P
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():851-4. PubMed ID: 19162790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous assessment of vessel size index, relative blood volume, and vessel permeability in a mouse brain tumor model using a combined spin echo gradient echo echo-planar imaging sequence and viable tumor analysis.
    Kording F; Weidensteiner C; Zwick S; Osterberg N; Weyerbrock A; Staszewski O; von Elverfeldt D; Reichardt W
    J Magn Reson Imaging; 2014 Dec; 40(6):1310-8. PubMed ID: 24390982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pancreatic cancer by multiple breath-hold dynamic contrast-enhanced magnetic resonance imaging at 3.0T.
    Yao X; Zeng M; Wang H; Sun F; Rao S; Ji Y
    Eur J Radiol; 2012 Aug; 81(8):e917-22. PubMed ID: 22695786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast enhanced magnetic resonance imaging of an orthotopic pancreatic cancer mouse model.
    Kim H; Samuel S; Totenhagen JW; Warren M; Sellers JC; Buchsbaum DJ
    J Vis Exp; 2015 Apr; (98):. PubMed ID: 25938718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced magnetic resonance imaging for pancreatic ductal adenocarcinoma at 3.0-T magnetic resonance: correlation with histopathology.
    Liu K; Xie P; Peng W; Zhou Z
    J Comput Assist Tomogr; 2015; 39(1):13-8. PubMed ID: 25340589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice.
    Sennino B; Raatschen HJ; Wendland MF; Fu Y; You WK; Shames DM; McDonald DM; Brasch RC
    Magn Reson Med; 2009 Sep; 62(3):616-25. PubMed ID: 19526501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
    Liu K; Xie P; Peng W; Zhou Z
    J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI.
    Pike MM; Stoops CN; Langford CP; Akella NS; Nabors LB; Gillespie GY
    Magn Reson Med; 2009 Mar; 61(3):615-25. PubMed ID: 19235262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts.
    Walker-Samuel S; Boult JK; McPhail LD; Box G; Eccles SA; Robinson SP
    Int J Cancer; 2012 Mar; 130(6):1284-93. PubMed ID: 21469141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to tumor microvasculature without contrast agents in high spectral and spatial resolution MR images.
    Foxley S; Fan X; Mustafi D; Haney C; Zamora M; Markiewicz E; Medved M; Wood AM; Karczmar GS
    Magn Reson Med; 2009 Feb; 61(2):291-8. PubMed ID: 19165878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic changes in murine vessel geometry assessed by high-resolution magnetic resonance angiography: a 9.4T study.
    Jacoby C; Böring YC; Beck A; Zernecke A; Aurich V; Weber C; Schrader J; Flögel U
    J Magn Reson Imaging; 2008 Sep; 28(3):637-45. PubMed ID: 18777558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing breast cancer angiogenesis in vivo: which susceptibility contrast MRI biomarkers are relevant?
    Kim E; Cebulla J; Ward BD; Rhie K; Zhang J; Pathak AP
    Magn Reson Med; 2013 Oct; 70(4):1106-16. PubMed ID: 23225578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetization transfer MRI in pancreatic cancer xenograft models.
    Li W; Zhang Z; Nicolai J; Yang GY; Omary RA; Larson AC
    Magn Reson Med; 2012 Oct; 68(4):1291-7. PubMed ID: 22213176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
    Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
    Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the maturity and functionality of tumor vasculature by MRI: correlation between BOLD-MRI and DCE-MRI using P792 in experimental fibrosarcoma tumors.
    Baudelet C; Cron GO; Gallez B
    Magn Reson Med; 2006 Nov; 56(5):1041-9. PubMed ID: 16986109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
    Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
    NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging.
    Zwick S; Strecker R; Kiselev V; Gall P; Huppert J; Palmowski M; Lederle W; Woenne EC; Hengerer A; Taupitz M; Semmler W; Kiessling F
    J Magn Reson Imaging; 2009 May; 29(5):1125-33. PubMed ID: 19388117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vessel size index magnetic resonance imaging to monitor the effect of antivascular treatment in a rodent tumor model.
    Howe FA; McPhail LD; Griffiths JR; McIntyre DJ; Robinson SP
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1470-6. PubMed ID: 18538948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.